Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Medicaid officials warn of high pharmacy costs from gene therapies and expanding GLP‑1 use
2731064 · March 21, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
Summary
Budget presenters told the Senate committee that new high-cost drugs — particularly one-time gene therapies and expanding clinical uses of GLP‑1 medicines — present a material cost risk not fully captured in the current fiscal estimate.
At the Senate Health & Welfare Committee meeting on March 20, Medicaid budget staff highlighted pharmacy as a significant area of uncertainty for next year's spending.
Presenters said the department's current estimate did not fully capture some emerging coverage pressures, including requests tied to sleep apnea and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans
